Skip to main content

Table 3 Univariate analysis of predictive factors for PFS

From: The role of initial 18F-FDG PET/CT in the management of patients with suspected extramedullary plasmocytoma

Factor

No. of patients

Progression rate,%

p value

Gender

 Male

7/13

53.8%

0.475

 Female

1/8

12.5%

 

Age

  ≤ 50

4/11

36.3%

0.835

  > 50

4/10

40.0%

 

Tumor size(cm)

  ≤ 4

3/12

25.0%

0.020*

  > 4

5/9

55.6%

 

Tumor number

 SP

5/18

27.8%

0.114

 MSP

3/3

100%

 

SUVmax

  ≤ 5.5

2/9

22.2%

0.627

  > 5.5

6/11

54.5%

 

Response to therapy

 CR

3/13

23.1%

0.040*

 PR

5/8

62.5%

 
  1. *p<0.05